Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

2002 • 4,335 citations

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

2005 • 3,088 citations

Nonalcoholic Fatty Liver Disease

2001 • 2,567 citations

Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

2001 • 2,021 citations

Molecular mediators of hepatic steatosis and liver injury

2004 • 1,763 citations

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

1998 • 1,728 citations

Molecular mediators of hepatic steatosis and liver injury

2004 • 1,709 citations

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

2006 • 1,700 citations

Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men

2002 • 1,057 citations

Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications

1995 • 1,026 citations

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

1989 • 799 citations

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

1997 • 789 citations

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

2004 • 729 citations

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

2003 • 716 citations

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

2005 • 710 citations

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

2006 • 698 citations

Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

2004 • 658 citations

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

2008 • 597 citations

Effects of Acute Changes of Plasma Free Fatty Acids on Intramyocellular Fat Content and Insulin Resistance in Healthy Subjects

2001 • 591 citations

Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

2007 • 576 citations

Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects

2008 • 564 citations

Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists

2000 • 535 citations

Effects of Rosiglitazone and Metformin on Liver Fat Content, Hepatic Insulin Resistance, Insulin Clearance, and Gene Expression in Adipose Tissue in Patients With Type 2 Diabetes

2004 • 530 citations

A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes

2003 • 496 citations

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

2009 • 494 citations

Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo

2005 • 449 citations

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

2004 • 438 citations

Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance

2006 • 385 citations

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

2004 • 359 citations

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

2001 • 279 citations

A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis

2000 • 265 citations

Contributions of Different Fatty Acid Sources to Very Low-Density Lipoprotein-Triacylglycerol in the Fasted and Fed States

2006 • 259 citations

Recent advances in nonalcoholic fatty liver disease

2009 • 214 citations

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

2007 • 202 citations

The Effect of Pioglitazone on Peroxisome Proliferator-Activated Receptor-γ Target Genes Related to Lipid Storage In Vivo

2004 • 194 citations

Lessons from animal models of NASH

2005 • 152 citations

Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?

2005 • 148 citations

Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease

2008 • 147 citations

Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ Agonists

2006 • 123 citations

Mitochondria in nonalcoholic fatty liver disease

2004 • 117 citations

New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)

2009 • 107 citations

Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes

2007 • 105 citations

Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes

2004 • 104 citations

Recent advances in nonalcholic fatty liver disease

2008 • 94 citations

The Effect of Pioglitazone on the Liver

2006 • 79 citations

Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARγ mRNA expression in 3T3-L1 adipocytes

2001 • 55 citations

Therapy of NAFLD: Insulin Sensitizing Agents.

2006 • 49 citations

Chronic Low‐Dose Lipid Infusion in Healthy Patients Induces Markers of Endothelial Activation Independent of Its Metabolic Effects

2008 • 21 citations

The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity

2009 • 14 citations